MYCO — Mydecine Innovations Balance Sheet
0.000.00%
Last trade - 00:00
- CA$0.93m
- CA$6.41m
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.011 | 0.018 | 2.19 | 1.5 | 4.63 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.217 | 0.012 | 0.041 | 0.205 | 0.363 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.493 | 0.601 | 2.5 | 5.22 | 6.21 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4.62 | 0.076 | 0.515 | 0.565 | 0.01 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 5.21 | 2.06 | 9.53 | 7.58 | 6.9 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.84 | 0.207 | 5.8 | 2.95 | 5.8 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.84 | 0.231 | 5.97 | 7.37 | 10.5 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 3.36 | 1.83 | 3.56 | 0.211 | -3.6 |
Total Liabilities & Shareholders' Equity | 5.21 | 2.06 | 9.53 | 7.58 | 6.9 |
Total Common Shares Outstanding |